TELA Bio, Inc. (TELA)
0.8301
+0.01
(+1.05%)
USD |
NASDAQ |
Sep 08, 16:00
0.85
+0.02
(+2.40%)
After-Hours: 20:00
TELA Bio Debt to Equity Ratio : -3.568 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | -3.568 |
| March 31, 2026 | -10.84 |
| December 31, 2025 | 9.133 |
| September 30, 2025 | 26.98 |
| June 30, 2025 | 4.562 |
| March 31, 2025 | 2.307 |
| December 31, 2024 | 1.513 |
| September 30, 2024 | -6.621 |
| June 30, 2024 | 14.42 |
| March 31, 2024 | 2.867 |
| December 31, 2023 | 2.265 |
| September 30, 2023 | 1.332 |
| June 30, 2023 | 1.014 |
| March 31, 2023 | 12.86 |
| December 31, 2022 | 2.898 |
| September 30, 2022 | 1.721 |
| Date | Value |
|---|---|
| June 30, 2022 | -26.77 |
| March 31, 2022 | 3.190 |
| December 31, 2021 | 1.567 |
| September 30, 2021 | 1.129 |
| June 30, 2021 | 0.8907 |
| March 31, 2021 | 0.7431 |
| December 31, 2020 | 0.6288 |
| September 30, 2020 | 0.5445 |
| June 30, 2020 | 0.4814 |
| March 31, 2020 | 1.254 |
| December 31, 2019 | 0.9768 |
| September 30, 2019 | -2.114 |
| June 30, 2019 | -2.496 |
| March 31, 2019 | |
| December 31, 2018 | -2.288 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Abbott Laboratories | 0.638 |
| AngioDynamics, Inc. | 0.0641 |
| Alphatec Holdings, Inc. | 52.37 |
| AtriCure, Inc. | 0.1437 |
| Baxter International, Inc. | 1.427 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 59.74M |
| Total Liabilities (Quarterly) | 75.60M |
| Shareholders Equity (Quarterly) | -15.87M |
| Current Ratio | 2.991 |
| Net Debt Paydown Yield | -8.81% |